Ultromics Receives FDA Clearance for AI-based Platform for Echocardiography

Ultromics has announced that its EchoGo Heart Failure, an artificial intelligence (AI) platform for echocardiography, with the potential to revolutionize the diagnosis of heart failure with preserved ejection fraction (HFpEF), has received US Food and Drug Administration (FDA) clearance.

Related Keywords

United States ,United Kingdom ,American ,Julie Gerberding ,Patriciaa Pellikka ,Ross Upton ,Foundation For The National Institutes Of Health ,American Heart Association ,National Institutes Of Health ,National Heart Lung ,Drug Administration ,Blood Institute ,United Kingdom University Of Oxford ,American Society Of Echocardiography ,Department Of Cardiovascular Medicine At Mayo Clinic ,Echogo Heart Failure ,National Institutes ,Accelerating Medicines Partnership Heart Failure ,American Society ,Vice Chair ,Cardiovascular Medicine ,Mayo Clinic ,Chief Executive Officer ,